Literature DB >> 19877735

Candida colonization and candiduria in critically ill patients in the intensive care unit.

Pierluigi Viale1.   

Abstract

Clinical severity of invasive candidiasis in critically ill patients and existing difficulties in timely diagnosis mean that early empirical therapy, based upon a strict clinical and epidemiological judgement, is required in intensive care unit patients. One school of thought is that the clinical severity and epidemiological burden of this disease warrant prophylaxis in all critically ill patients. In reality, however, there are still many open-ended questions with regard to which variables are most apt for selection of patients requiring prophylactic or empirical treatment. As a consequence of a consistently significant correlation between colonization (one or more Candida-positive cultures from non-sterile sites) and subsequent infection, colonization remains the most universally accepted predictive variable with regard to invasive candidiasis. This is particularly true for high density colonization. It has not yet been clarified whether colonization can be used in isolation to identify high-risk patients or if it should be combined with other variables indicating high risk. Additionally, there is still a debate surrounding the question as to whether determination of multisite colonization is required, or whether detecting colonization at one or two specific sites is sufficient for the identification of high-risk patients. From a practical perspective, candiduria (a frequent finding in critically ill patients) appears one of the most promising parameters with regard to single-site assessment, owing to easy sampling procedures. Definitive evidence of a correlation between candiduria and invasive candidiasis is currently still lacking, as the few published studies thus far have yielded conflicting results. It is, however, apparent that candiduria can be reliably considered a surrogate marker of high density of colonization, thereby potentially representing a more practical, less resource-intensive screening marker of heavy colonization and high risk of infection than is currently possible using parameters such as the multiple-site colonization index.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877735     DOI: 10.2165/11315640-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  36 in total

1.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

Authors:  Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden
Journal:  Clin Infect Dis       Date:  2006-05-16       Impact factor: 9.079

Review 2.  Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

Authors:  E G Playford; A C Webster; T C Sorrell; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 3.  Invasive fungal infections: evolving challenges for diagnosis and therapeutics.

Authors:  Michael Ellis
Journal:  Mol Immunol       Date:  2002-05       Impact factor: 4.407

4.  Effects of nosocomial candidemia on outcomes of critically ill patients.

Authors:  Stijn I Blot; Koenraad H Vandewoude; Eric A Hoste; Francis A Colardyn
Journal:  Am J Med       Date:  2002-10-15       Impact factor: 4.965

5.  Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.

Authors:  Jaffar A Al-Tawfiq
Journal:  Int J Infect Dis       Date:  2006-07-21       Impact factor: 3.623

6.  Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia.

Authors:  Elie Azoulay; Jean-François Timsit; Muriel Tafflet; Arnaud de Lassence; Michael Darmon; Jean-Ralph Zahar; Christophe Adrie; Maité Garrouste-Orgeas; Yves Cohen; Bruno Mourvillier; Benoît Schlemmer
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

7.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

8.  Candida sepsis. Implications of polymicrobial blood-borne infection.

Authors:  D L Dyess; R N Garrison; D E Fry
Journal:  Arch Surg       Date:  1985-03

9.  Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

Authors:  Mindy G Schuster; John E Edwards; Jack D Sobel; Rabih O Darouiche; Adolf W Karchmer; Susan Hadley; Gus Slotman; Helene Panzer; Pinaki Biswas; John H Rex
Journal:  Ann Intern Med       Date:  2008-07-15       Impact factor: 25.391

Review 10.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.

Authors:  Benoît P Guery; Maiken C Arendrup; Georg Auzinger; Elie Azoulay; Márcio Borges Sá; Elizabeth M Johnson; Eckhard Müller; Christian Putensen; Coleman Rotstein; Gabriele Sganga; Mario Venditti; Rafael Zaragoza Crespo; Bart Jan Kullberg
Journal:  Intensive Care Med       Date:  2008-10-30       Impact factor: 17.440

View more
  14 in total

Review 1.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

2.  Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections.

Authors:  Pasquale De Bellis
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 3.  Insights into Candida tropicalis nosocomial infections and virulence factors.

Authors:  M Negri; S Silva; M Henriques; R Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-30       Impact factor: 3.267

4.  [Candiduria! What now? : Therapy of urinary tract infections with Candida].

Authors:  H Hof
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

5.  Invasive Candida infections in patients of a medical intensive care unit: attempt of improving diagnosis by quantifying the colonization.

Authors:  Sebastian Kautzky; Thomas Staudinger; Elisabeth Presterl
Journal:  Wien Klin Wochenschr       Date:  2014-11-21       Impact factor: 1.704

6.  Detection of Candida albicans by mass spectrometric fingerprinting.

Authors:  Sarah Zehm; Simone Schweinitz; Reinhard Würzner; Hans Peter Colvin; Josef Rieder
Journal:  Curr Microbiol       Date:  2011-12-16       Impact factor: 2.188

7.  Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions.

Authors:  Zhengxin He; Xiaosai Huo; Daxin Lei; Huihai Zhao; Keran Jia; Fukun Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-30       Impact factor: 3.267

8.  Editorial: The Risky Business of Fungal Infections in Patients with Cirrhosis.

Authors:  Lisa Brumble; Andrew P Keaveny
Journal:  Am J Gastroenterol       Date:  2018-04       Impact factor: 10.864

9.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

Review 10.  An Italian consensus for invasive candidiasis management (ITALIC).

Authors:  L Scudeller; C Viscoli; F Menichetti; V del Bono; F Cristini; C Tascini; M Bassetti; P Viale
Journal:  Infection       Date:  2013-11-25       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.